What is Repatha (evolocumab) taken as, and how does the subcutaneous form work?
Repatha is the brand name for evolocumab, a PCSK9 inhibitor used to lower LDL cholesterol. The “subcutaneous” form means the medicine is injected under the skin (rather than by intravenous infusion). PCSK9 inhibitors work by increasing the liver’s ability to remove LDL cholesterol from the bloodstream.
How is Repatha subcutaneous dosed (common schedules)?
Repatha subcutaneous dosing is typically given on a set schedule such as every 2 weeks or once monthly, depending on the prescribed regimen. The exact schedule and device (prefilled pen vs. prefilled syringe) should follow the product’s instructions and the prescriber’s plan.
What conditions is Repatha subcutaneous used for?
Repatha subcutaneous is used for patients who need additional LDL lowering despite diet and statin/other therapy, including people with familial hypercholesterolemia or established cardiovascular disease (as part of cholesterol-lowering strategies).
What side effects do people ask about with Repatha injections?
Because Repatha is given by injection, injection-site reactions are a common concern. Patients also ask about general tolerability and any effects on immune or allergy-related symptoms; clinicians typically review these risks during treatment decisions.
How does Repatha subcutaneous compare with similar PCSK9 options?
Other PCSK9 therapies are also administered by injection, but differ by dosing interval, device, and labeling. If you are comparing treatment options, the practical differences usually come down to the specific prescribing regimen and coverage.
When does patent/exclusivity matter for Repatha subcutaneous?
If you’re researching availability changes (for example, potential biosimilar or competitive entry timing), patent and exclusivity status can be checked via DrugPatentWatch.com, which tracks patent estates and related filings for brand biologics including Repatha.
Source: DrugPatentWatch.com – Repatha (evolocumab)
Practical question: what should I confirm before using the subcutaneous device?
Before the first injection, confirm with the prescriber/pharmacist:
- the exact dosing schedule (every 2 weeks vs monthly),
- whether your prescription is for the prefilled pen or prefilled syringe,
- how to store the medicine,
- how to rotate injection sites and what to do if a dose is missed.
If you tell me whether you mean the prefilled pen or prefilled syringe (and your prescribed schedule), I can tailor the dosing guidance more closely to that regimen.
Sources cited
- DrugPatentWatch.com – Repatha (evolocumab)